NRD
IDYA icon

Nebula Research & Development’s IDEAYA Biosciences IDYA Stock Holding History

Nebula Research & Development’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-60,767
Closed -$1.28M – 422
2025
Q2 		$1.28M Sell
60,767
-28,791
-32% -$552K 0.11% 314
2025
Q1 		$1.47M Buy
89,558
+14,141
+19% +$301K 0.14% 254
2024
Q4 		$1.94M Buy
75,417
+4,654
+7% +$132K 0.23% 113
2024
Q3 		$2.24M Buy
70,763
+38,393
+119% +$1.46M 0.27% 74
2024
Q2 		$1.14M Buy
32,370
+12,706
+65% +$503K 0.18% 183
2024
Q1 		$863K Buy
+19,664
New +$845K 0.19% 183

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nebula Research & Development's IDYA Position: Q3 2025 in Review

Nebula Research & Development sold out of IDEAYA Biosciences (IDYA) in Q3 2025, closing a stake of 60,767 shares — an estimated $1.28M sold.

Nebula Research & Development first reported a position in IDYA in Q1 2024 and held it in 6 quarters. The position peaked at $2.24M in Q3 2024. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Nebula Research & Development reported no remaining IDEAYA Biosciences position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 60,767 IDEAYA Biosciences shares in Q3 2025, an estimated $1.28M.
  • Nebula Research & Development first reported a position in IDEAYA Biosciences in Q1 2024 and held it in 6 quarters.
  • Nebula Research & Development's IDEAYA Biosciences position peaked at $2.24M in Q3 2024.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.